GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Net Margin %

Universal Ibogaine (TSXV:IBO) Net Margin % : -37.69% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Universal Ibogaine's Net Income for the three months ended in Jan. 2024 was C$-0.22 Mil. Universal Ibogaine's Revenue for the three months ended in Jan. 2024 was C$0.59 Mil. Therefore, Universal Ibogaine's net margin for the quarter that ended in Jan. 2024 was -37.69%.

The historical rank and industry rank for Universal Ibogaine's Net Margin % or its related term are showing as below:

TSXV:IBO' s Net Margin % Range Over the Past 10 Years
Min: -980.02   Med: -606.03   Max: -53.35
Current: -53.35


TSXV:IBO's Net Margin % is ranked better than
61.5% of 1026 companies
in the Biotechnology industry
Industry Median: -150.095 vs TSXV:IBO: -53.35

Universal Ibogaine Net Margin % Historical Data

The historical data trend for Universal Ibogaine's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Net Margin % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Net Margin %
Get a 7-Day Free Trial - - - -980.02 -232.04

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,934.15 -113.79 -48.04 -32.20 -37.69

Competitive Comparison of Universal Ibogaine's Net Margin %

For the Biotechnology subindustry, Universal Ibogaine's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Net Margin % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Net Margin % falls into.



Universal Ibogaine Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Universal Ibogaine's Net Margin for the fiscal year that ended in Jul. 2023 is calculated as

Net Margin=Net Income (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-2.39/1.03
=-232.04 %

Universal Ibogaine's Net Margin for the quarter that ended in Jan. 2024 is calculated as

Net Margin=Net Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.222/0.589
=-37.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Universal Ibogaine Net Margin % Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines